16
Participants
Start Date
June 9, 2025
Primary Completion Date
March 2, 2028
Study Completion Date
March 2, 2029
Avacopan
Avacopan is a complement 5a receptor (C5aR) antagonist, orally active.
Prednisone
0.4 mg/kg per day (maximum, 32 mg/day) for 2 months followed by dose tapering by 4 mg per day each month (total duration 6-9 months
Methylprednisolone (drug)
Methylprednisolone 1g intravenous on day +1
Prednisolone
Prednisone 0.2 mg/kg per day (maximum, 16 mg/day) for 2 months followed by dose tapering by 2 mg per day each month (total duration 6-9 months)
RECRUITING
Mayo Clinic in Florida, Jacksonville
RECRUITING
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER